Revenue
-
Net Income
-$80.6M
▼ 118.1% YoY
EPS
$-1.32
▼ 57.1% YoY
Cash
$33.2M
▲ 24.2% YoY
FY 2024 · As of 2024-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Flynn James E | Buy | Feb 27, 2026 | 1.08M | $5.00 | $5.42M | Form 4 ↗ |
Flynn James E | Buy | Feb 27, 2026 | 1.08M | $5.00 | $5.42M | Form 4 ↗ |
Flynn James E | Buy | Feb 27, 2026 | 832.0K | $5.00 | $4.16M | Form 4 ↗ |
Flynn James E | Buy | Feb 27, 2026 | 2.00M | $5.00 | $10.00M | Form 4 ↗ |
Hamilton Thomas Edward Insider | Buy | Feb 27, 2026 | 100.0K | $5.00 | $500K | Form 4 ↗ |
THOMAS FRANK E Insider | Buy | Feb 27, 2026 | 5.0K | $5.00 | $25K | Form 4 ↗ |
SHERMAN JEFFREY W Insider | Buy | Feb 27, 2026 | 5.0K | $5.00 | $25K | Form 4 ↗ |
Shankar Gopi Chief Development Officer | Grant | Jan 26, 2026 | 25.6K | $0.00 | $0 | Form 4 ↗ |
Clayton Russell Chief Medical Officer | Grant | Jan 26, 2026 | 25.6K | $0.00 | $0 | Form 4 ↗ |
BEN-MAIMON CAROLE President and CEO | Grant | Jan 26, 2026 | 100.1K | $0.00 | $0 | Form 4 ↗ |
Celano Michael Chief Financial Officer | Grant | Jan 26, 2026 | 37.6K | $0.00 | $0 | Form 4 ↗ |